You haven't searched anything yet.
Kernal Bio is a VC-backed Biotech company that is creating mRNA drugs that instruct specific cells in the body on how to make their own medicine. Messenger RNA technology has proven extremely useful in rapidly developing vaccines against COVID-19. Kernal Bio is developing the next generation of mRNA therapy, called mRNA 2.0. It solves a critical problem of cancer cell selectivity that affects mRNA and oncolytic virus-based immuno-oncology drugs. Located in Cambridge, MA, Kernal Bio received three awards from Amgen and NASA. With roots at MIT, Harvard, and Big Pharma, Kernal Bio’s interdisciplinary team of MDs and PhDs previously built a successful Biotech company and has deep expertise in mRNA and oncology space.
Job Summary:
Kernal Bio is seeking an exceptional and highly motivated Research Associate or Sr. Research Associate that will contribute to the development of its mRNA 2.0 platform for therapeutic applications. The successful candidate will work as part of the team responsible for producing, characterizing, and testing Lipid Nanoparticles (LNPs) for mRNA delivery. Candidate should be proficient in LNP workflows and in vitro lab techniques.
Responsibilities:
Requirements:
Benefits:
Kernal is dedicated to providing a diverse work environment and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in employment practices for reasons of race, color, national origin, age, gender, sexual orientation, marital or veteran status, religion, disability, or any other legally protected status. Kernal will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Full Time
Contract Research
$96k-121k (estimate)
02/15/2023
05/17/2024
kernalbio.com
Cambridge, MA
<25
Contract Research